# Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics Page: https://stenobird.com/podcast/stocks-to-watch-5696376/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics Text version: https://stenobird.com/podcast/stocks-to-watch-5696376/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics.md Podcast: [Stocks To Watch](https://stenobird.com/podcast/stocks-to-watch-5696376) Published: 2026-05-27T15:14:51+00:00 Episode link: https://www.podomatic.com/podcasts/stockstowatch/episodes/2026-05-27T08_14_51-07_00 Audio file: https://pdcn.co/e/stockstowatch.podomatic.com/enclosure/2026-05-27T08_14_51-07_00.mp3?_=1779894894.17784777 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics Duration seconds: 1518 ## Resource This interview is disseminated on behalf of Conexeu Sciences Inc. Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration. Learn more: https://www.conexeu.com/ Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hU And follow us to stay updated: https://www.youtube.com/GlobalOneMedia ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/stocks-to-watch-5696376/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.